Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute-on-Chronic Liver Failure Clinical Guidelines
Jasmohan S. Bajaj, Jacqueline G. O’Leary, Jennifer C. Lai, et al.
The American Journal of Gastroenterology (2022)
Open Access | Times Cited: 146

Showing 1-25 of 146 citing articles:

Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US
Kavish R. Patidar, Justin M. Belcher, Kevin R. Regner, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. 1408-1417
Closed Access | Times Cited: 46
Acute-on-chronic liver failure (ACLF): the ‘Kyoto Consensus’—steps from Asia
Ashok Choudhury, Anand V. Kulkarni, Vinod Arora, et al.
Hepatology International (2025) Vol. 19, Iss. 1, pp. 1-69
Open Access | Times Cited: 2
Acute-on-chronic liver failure: far to go—a review
Jinjin Luo, Jiaqi Li, Peng Li, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 25
Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation
Dong‐Sik Kim, Young‐In Yoon, Beom Kyung Kim, et al.
Hepatology International (2024) Vol. 18, Iss. 2, pp. 299-383
Open Access | Times Cited: 15
High-density lipoprotein cholesterol as a prognostic marker for 90-day transplant-free mortality in hepatitis B virus-related acute-on-chronic liver failure
Ke Shi, Yi Zhang, Yanqiu Li, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 14
Open Access | Times Cited: 1
Exploring drug-induced liver injury: comprehensive insights into mechanisms and management of hepatotoxic agents
Asmaa Saleh, Thanaa A. El‐Masry, Aya H. El-Kadem, et al.
Future Journal of Pharmaceutical Sciences (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?
Nadir Abbas, Neil Rajoriya, Ahmed M. Elsharkawy, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 7, pp. 639-652
Open Access | Times Cited: 33
Intensive care management of acute-on-chronic liver failure
Giovanni Perricone, Thierry Artzner, Eléonora De Martin, et al.
Intensive Care Medicine (2023) Vol. 49, Iss. 8, pp. 903-921
Closed Access | Times Cited: 20
Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
Rakesh Kumar Jagdish, Akash Roy, Karan Kumar, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 17
Inflammation drives pathogenesis of early intestinal failure-associated liver disease
Scott C. Fligor, Savas T. Tsikis, Thomas I. Hirsch, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Acute-on-Chronic Liver Failure
Jasmohan S. Bajaj, Florence Wong, Patrick S. Kamath, et al.
The American Journal of Gastroenterology (2022) Vol. 117, Iss. 6, pp. 831-834
Closed Access | Times Cited: 23
Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis
Jody C. Olson, Ram Subramanian
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0296690-e0296690
Open Access | Times Cited: 6
Geographic disparities in access to liver transplant for advanced cirrhosis: Time to ring the alarm!
Jasmohan S. Bajaj, Ashok Choudhury, Vinay Kumaran, et al.
American Journal of Transplantation (2024) Vol. 24, Iss. 5, pp. 733-742
Closed Access | Times Cited: 5
Outcome of patients with different stages of acute-on-chronic liver failure treated with artificial liver support system
Yuanji Ma, Yan Xu, Lingyao Du, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation
Alexandre Sitbon, Pierre-Romain Delmotte, Valéria Pistorio, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Sarcopenia is associated with short‐ and long‐term mortality in patients with acute‐on‐chronic liver failure
Fan Zeng, Wei Jiang, Xiujun Chang, et al.
Journal of Cachexia Sarcopenia and Muscle (2024) Vol. 15, Iss. 4, pp. 1473-1482
Open Access | Times Cited: 5
Acute-on-chronic liver failure: Controversies and consensus
Natalie LY Ngu, Eliza Flanagan, Sally Bell, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 2, pp. 232-240
Open Access | Times Cited: 11
The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution
Yu Xia, Xinxin Liu, Wenting Tan, et al.
Hepatology Communications (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 4
Global acute-on-chronic liver failure trends during 2012–2022: A bibliometric study
Cheng-zhi Bai, Juan Ren, Xue Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e25791-e25791
Open Access | Times Cited: 4
Larsucosterol: endogenous epigenetic regulator for treating chronic and acute liver diseases
Yaping Wang, Jenna Ren, Shunlin Ren
AJP Endocrinology and Metabolism (2024) Vol. 326, Iss. 5, pp. E577-E587
Open Access | Times Cited: 4
Chishao - Fuzi herbal pair restore the macrophage M1/M2 balance in acute-on-chronic liver failure
Nian-Hua Tan, Gonghui Jian, PENG Jie, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118010-118010
Closed Access | Times Cited: 4
Review article: Evaluation and care of the critically ill patient with cirrhosis
Iva Košuta, Madhumita Premkumar, K. Rajender Reddy
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 12, pp. 1489-1509
Closed Access | Times Cited: 4
Association Between Artificial Liver Support System and Prognosis in Hepatitis B Virus-Related Acute-on-Chronic Liver Failure
Kunping Cui, Changhai Liu, Xiangnan Teng, et al.
Infection and Drug Resistance (2025) Vol. Volume 18, pp. 113-126
Open Access
Cirrhosis and Truly Elective Major Surgery
Simona Jakab, Adriana D. Oprea
Perioperative Medicine (2025), pp. 249-258
Open Access
Plasma galectin-3 can be considered as a non-invasive marker to predict the prognosis of ACLF patients with new typing
Bai Li, Lu Wang, Huazhe Yang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top